Checkpoint inhibition induced pruritus during cancer therapy is associated with skin IL-31 and CCL22 expression Meeting Abstract


Authors: Wang, E.; Lyubchenko, T.; Goleva, E.; Kraehenbuehl, L.; Ketosugbo, K.; Moy, A.; Hellmann, M.; Kern, J.; Lacouture, M.; Leung, D.
Abstract Title: Checkpoint inhibition induced pruritus during cancer therapy is associated with skin IL-31 and CCL22 expression
Meeting Title: 2022 AAAAI Annual Meeting of the American Academy of Allergy, Asthma & Immunology
Journal Title: Journal of Allergy and Clinical Immunology
Volume: 149
Issue: 2 Suppl.
Meeting Dates: 2022 Feb 25-28
Meeting Location: Phoenix, AZ
ISSN: 0091-6749
Publisher: Mosby Elsevier  
Date Published: 2022-02-01
Start Page: AB173
Language: English
ACCESSION: WOS:000778999300518
PROVIDER: wos
DOI: 10.1016/j.jaci.2021.12.573
Notes: Meeting Abstract: 520 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mario E Lacouture
    457 Lacouture
  2. Matthew David Hellmann
    411 Hellmann
  3. Andrea Primiani Moy
    32 Moy